Orion Biotech Opportunities Corp – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/22 FY 2022

ended 09/30/22 Q3

ended 06/30/22 Q2

ended 03/31/22 Q1

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Business combination disclosure

Prospectus supplement with pricing info

Registration of securities on exchange

Ownership Filter

683 Capital Management, LLC

Huang James, Orion Sponsor Holdings, LLC

Collins James J.

Rodriguez Louisa

News Filter

Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination

Non-Reliance on Previously Issued Financial Statements or Related Audit Report or Completed Interim Review

Announces the Separate Trading of Its Class a Ordinary Shares and Warrants Commencing July 2, 2021

Report of Independent Registered Public Accounting Firm

Announces Pricing of $200,000,000 Initial Public Offering

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC